Christoph Laske

Hoppe Seyler Str. 3
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 189 publications

Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-AD.

Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-AD.

Journal: medRxiv : the preprint server for health sciences

Published: July 10, 2026

Diagnostic Images for Mild Cognitive Impairment Are Sensitive to Alzheimer's Disease Biomarkers and Reveal Abnormal Scene Processing.

Diagnostic Images for Mild Cognitive Impairment Are Sensitive to Alzheimer's Disease Biomarkers and Reveal Abnormal Scene Processing.

Journal: Journal of cognitive neuroscience

Published: July 07, 2026

Non-economic social deprivation and cognitive functioning later in life: Results from the DELCODE study.

Non-economic social deprivation and cognitive functioning later in life: Results from the DELCODE study.

Journal: Journal of Alzheimer's disease : JAD

Published: May 12, 2026

Disruption of temporo-parietal network in Alzheimer's disease and its association with memory impairment.

Disruption of temporo-parietal network in Alzheimer's disease and its association with memory impairment.

Journal: Alzheimer's research & therapy

Published: March 17, 2026

Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry Study.

Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry Study.

Journal: Neurology

Published: February 23, 2026

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment.

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment.

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment.

Journal: The journal of prevention of Alzheimer's disease

Published: February 05, 2026

Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease.

Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease.

Journal: The journal of prevention of Alzheimer's disease

Published: January 08, 2026

Polygenic risk for psychiatric disorders and its association with neuropsychiatric symptoms in dementia.

Polygenic risk for psychiatric disorders and its association with neuropsychiatric symptoms in dementia.

Journal: International review of psychiatry (Abingdon, England)

Published: December 24, 2025

Pathways to resilience: relationships between cognitive reserve, psychological debt, and Alzheimer's disease biomarkers.

Pathways to resilience: relationships between cognitive reserve, psychological debt, and Alzheimer's disease biomarkers.

Journal: Alzheimer's research & therapy

Published: December 19, 2025

Associations of anticholinergic burden of medication with cognitive decline and longitudinal brain atrophy in the Alzheimer's disease spectrum.

Associations of anticholinergic burden of medication with cognitive decline and longitudinal brain atrophy in the Alzheimer's disease spectrum.

Journal: Frontiers in aging neuroscience

Published: November 21, 2025

Predicting longitudinal basal forebrain volume in the Alzheimer's disease spectrum: the role of sex and ApoE epsilon 4 genotype.

Predicting longitudinal basal forebrain volume in the Alzheimer's disease spectrum: the role of sex and ApoE epsilon 4 genotype.

Journal: Frontiers in neuroscience

Published: October 23, 2025

Showing 1-12 of 189

Last Updated: 09/26/2026